Detalhe da pesquisa
1.
Sleep-wake behavior, perceived fatigability, and cognitive reserve in older adults.
Alzheimers Dement
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38690777
2.
Effects of age on the relationship between sleep quality and cognitive performance: Findings from the Human Connectome Project-Aging cohort.
Int Psychogeriatr
; : 1-11, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047419
3.
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
J Infect Dis
; 222(8): 1334-1344, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32406487
4.
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy.
J Infect Dis
; 222(4): 601-610, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201883
5.
Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials.
J Viral Hepat
; 27(5): 497-504, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954087
6.
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.
J Med Virol
; 92(12): 3459-3464, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829433
7.
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Br J Clin Pharmacol
; 86(1): 132-142, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31656054
8.
Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.
J Viral Hepat
; 26(3): 362-372, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450781
9.
Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy.
J Med Virol
; 91(7): 1307-1312, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30840774
10.
Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.
Eur J Clin Pharmacol
; 75(2): 207-216, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291369
11.
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.
J Infect Dis
; 217(3): 474-482, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228392
12.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30600291
13.
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis.
J Hepatol
; 67(4): 700-707, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645740
14.
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.
N Engl J Med
; 370(3): 222-32, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428468
15.
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
Gastroenterology
; 150(7): 1590-1598, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976799
16.
Exploratory study of oral combination antiviral therapy for hepatitis C.
N Engl J Med
; 368(1): 45-53, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23281975
17.
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.
J Hepatol
; 63(2): 364-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25839406
18.
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1.
J Hepatol
; 59(1): 18-23, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439262
19.
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity.
PLoS Negl Trop Dis
; 17(7): e0011392, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428804
20.
Effects of a ritonavir-containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects.
Pharmacol Res Perspect
; 10(6): e01024, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416673